Sand Hill Global Advisors, LLC Corcept Therapeutics Inc Transaction History

Sand Hill Global Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $122,700 - $156,500	-10,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $123,000 - $193,000	10,000	10,000 $193,000

315

93.8M

2.02M

3.24M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.38B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Sand Hill Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sand Hill Global Advisors, LLC with notifications on news.